Blog

Publication – OpenSPR Binding Data Reveals a Novel Approach to Treat Chronic Itch

Cut Your Lab Instrument Downtime to 0 Using OpenSPR™

App Note: Binding Kinetics of Protein-Protein Interactions using OpenSPR™

New Publication – OpenSPR Binding Data Establishes A Novel In Vivo Imaging Technique

New Publication – OpenSPR Binding Data Enhances Nanotherapeutic Construction with Molecular Affinity Strategy

OpenSPR Binding Data Uncovers Antipsychotic Drug Mechanisms

Binding Kinetics of Aptamer-Protein Interactions using OpenSPR

Binding Kinetics of Glycoprotein Interactions using OpenSPR

Binding Kinetics of Protein-Protein Interactions using OpenSPR

Binding Kinetics of Ubiquitin to Ubiquitin Antibody Immobilized with Protein A using OpenSPR

Binding Kinetics of Therapeutic Monoclonal Antibodies to the CD16a Fc Receptor using OpenSPR

Temperature Dependent Binding Kinetics of Protein-Protein Interactions Using OpenSPR

Binding Kinetics of Protein-Small Molecule Interactions using OpenSPR

OpenSPR 2-Channel Instrument for Protein Interaction Analysis

OpenSPR Binding Data Uncovers Virulence Mechanism of Streptococcus pyogenes

Advancing Neuromuscular Disease Research with OpenSPR Binding Data

OpenSPR Binding Data Advances Delivery Method of Photodynamic Cancer Therapeutics

Dr. Xiaofeng Liu recently published a paper using binding data generated from OpenSPR to reveal an effective affibody-based photosensitizer carrier used in Photodynamic Therapy (PDT), a less invasive alternative to cancer treatments. Read the full article to see how OpenSPR provided Dr. Xiaofeng Liu with the key binding data needed to advance PDT.

OpenSPR-XT Binding Data Opens New Doors for Targeting of RNA Binding Proteins for Glioblastoma Therapeutics

Dr. Luis Penalva recently published a paper using binding data generated from the OpenSPR-XT’s automated SPR technology assessing the effectiveness of luteolin binding to RNA binding protein, Msi1. Read the full article to see how OpenSPR-XT provided Dr. Penalva with the key binding data needed for his latest discovery of an effective glioblastoma treatment.